Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT.
Over the last 25 years, the numbers of hematopoietic stem cell transplant (SCT) patients have increased rapidly. Infections have been major obstacles for successful transplantation. Thus, infection prevention is very important in transplant recipients. As the results of transplantation have improved, the number of long-term survivors has increased. Vaccination is a potentially important strategy for reducing the risk for vaccine-preventable infections after SCT. The EBMT produced recommendations for vaccination of SCT recipients published in Bone Marrow Transplantation in 1995. This paper updates the previous recommendations based on current knowledge.
Ljungman
P
P
Department of Hematology, Karolinska University Hospital/Huddinge, Stockholm, Sweden. Per.Ljungman@medhs.ki.se
Engelhard
D
D
de la Cámara
R
R
Einsele
H
H
Locasciulli
A
A
Martino
R
R
Ribaud
P
P
Ward
K
K
Cordonnier
C
C
D002986:Clinical Trials as Topic; D003140:Communicable Disease Control / Q000379:methods; D003141:Communicable Diseases; D005060:Europe; D006287:Health Planning Guidelines; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D007115:Immunization Schedule; D017053:Infection Control / Q000379:methods; D009894:Opportunistic Infections / Q000517:prevention & control*; D012306:Risk; D014611:Vaccination / Q000592:standards*